16:17 EDT Can-Fite BioPharma files $100M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CANF:
- Can-Fite BioPharma reports 1H revenue $390K vs. $410K for 1H last year
- CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Can-Fite BioPharma plans to develop Piclidenoson for treatment of Lowe Syndrome
- Can-Fite BioPharma submits Piclidenoson pediatric study plan to FDA
- Can-Fite BioPharma price target raised to $12 from $8.25 at Alliance Global Partners